A Study in Subjects With Perennial Allergic Rhinitis

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

PHASE2

Total Enrollment

630 participants

Study Classification

INTERVENTIONAL

Study Start Date

2002-12-31

Study Completion Date

2003-04-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study was to determine the efficacy and safety of the study drug compared to placebo for the treatment of subjects with perennial allergic rhinitis.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Study Of Perennial Allergic Rhinitis

NCT00358475

Rhinitis, Allergic, Seasonal

COMPLETED PHASE3

A Study of Epinastine Nasal Spray in Subjects With Seasonal Allergic Rhinitis

NCT00407927

Seasonal Allergic Rhinitis

COMPLETED PHASE2

Perennial Allergic Rhinitis Study In Pediatric Subjects

NCT00108914

Rhinitis, Allergic, Perennial

COMPLETED PHASE3

To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis Patients

NCT03655210

Perennial Allergic Rhinitis

COMPLETED PHASE3

Seasonal Allergic Rhinitis In Pediatric Subjects

NCT00107757

Rhinitis, Allergic, Perennial

COMPLETED PHASE3

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Perennial Allergic Rhinitis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

DOUBLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

INS37217 Nasal Spray

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Have a documented history of allergy to perennial allergens and demonstrated sensitivity by the results of prick or intradermal skin testing.
* Have a self-reported history of at least mild, intermittent rhinorrhea and nasal blockage/stuffiness due to allergies.
* Have not started or had a change in immunotherapy regimen.

Exclusion Criteria

* Have a physical obstruction in the nose.
* Will likely have an acute increase in severity of allergic rhinitis due to seasonal aeroallergens during the trial.
* Have acute or chronic sinusitis or had previous sinus surgery resulting in a significant change in the sinus or nasal anatomy.
* Have rhinitis medicamentosa or any other acute or chronic condition that could confound evaluations of nasal symptoms.
* Have asthma of sufficient severity to require use of excluded medications.
* Have taken any medications excluded as listed in the protocol.
* Have a clinically significant acute or chronic disease or clinically significant laboratory abnormality.
* Are a current smoker, recent smoker or past smoker as defined in the protocol.

Eligible Sex

Accepts Healthy Volunteers

No